Abstract
Gastric carcinoma is one of the major causes of cancer mortality worldwide. Early detection results in excellent prognosis for patients with early cancer (EGC), whereas the prognosis of advanced cancer (AGC) patients remains poor. It is not clear whether EGC and AGC are molecularly distinct, and whether they represent progressive stages of the same tumor or different entities ab initio. Gene expression profiles of EGC and AGC were determined by Affymetrix technology and quantitative polymerase chain reaction. Representative regulated genes were further analysed by in situ hybridization (ISH) on tissue microarrays. Expression analysis allowed the identification of a signature that differentiates AGC from EGC. In addition, comparison with normal gastric mucosa indicated that the majority of alterations associated with EGC are retained in AGC, and that further expression changes mark the transition from EGC to AGC. Finally, ISH analysis showed that representative genes, differentially expressed in the invasive areas of EGC and AGC, are not differentially expressed in the non-invasive areas of the same tumors. Our data are more directly compatible with a progression model of gastric carcinogenesis, whereby EGC and AGC may represent different molecular stages of the same tumor. Finally, the identification of an AGC-specific signature might help devising novel therapeutic strategies for advanced gastric cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
Accessions
GenBank/EMBL/DDBJ
References
Balkwill F, Mantovani A . (2001). Inflammation and cancer: back to Virchow? Lancet 357: 539–545.
Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S et al. (2004). TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303: 848–851.
Boussioutas A, Li H, Liu J, Waring P, Lade S, Holloway AJ et al. (2003). Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer. Cancer Res 63: 2569–2577.
Cunha GR, Hayward SW, Wang YZ, Ricke WA . (2003). Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer 107: 1–10.
Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM . (2005). Gastric adenocarcinoma: review and considerations for future directions. Ann Surg 241: 27–39.
Eberwine J, Yeh H, Miyashiro K, Cao Y, Nair S, Finnell R et al. (1992). Analysis of gene expression in single live neurons. Proc Natl Acad Sci U S A 89: 3010–3014.
Farrell JJ, Taupin D, Koh TJ, Chen D, Zhao CM, Podolsky DK et al. (2002). TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury. J Clin Invest 109: 193–204.
Hasegawa S, Furukawa Y, Li M, Satoh S, Kato T, Watanabe T et al. (2002). Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. Cancer Res 62: 7012–7017.
Henderson BE . (1990). Summary report of the sixth symposium on cancer registries and epidemiology in the Pacific Basin. J Natl Cancer Inst 82: 1186–1190.
Hippo Y, Yashiro M, Ishii M, Taniguchi H, Tsutsumi S, Hirakawa K et al. (2001). Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res 61: 889–895.
Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H et al. (2004). Gastric cancer originating from bone marrow-derived cells. Science 306: 1568–1571.
Jinawath N, Furukawa Y, Hasegawa S, Li M, Tsunoda T, Satoh S et al. (2004). Comparison of gene-expression profiles between diffuse- and intestinal-type gastric cancers using a genome-wide cDNA microarray. Oncogene 23: 6830–6844.
Kajitani T . (1981). The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification. Jpn J Surg 11: 127–139.
Katoh M . (2003). CLDN23 gene, frequently down-regulated in intestinal-type gastric cancer, is a novel member of CLAUDIN gene family. Int J Mol Med 11: 683–689.
Kim B, Bang S, Lee S, Kim S, Jung Y, Lee C et al. (2003). Expression profiling and subtype-specific expression of stomach cancer. Cancer Res 63: 8248–8255.
Kirikoshi H, Katoh M . (2002). Expression of TFF1, TFF2 and TFF3 in gastric cancer. Int J Oncol 21: 655–659.
Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S et al. (1998). Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844–847.
Lawrence M, Shiu MH . (1991). Early gastric cancer. Twenty-eight-year experience. Ann Surg 213: 327–334.
Lee JH, Choi SR, Hwang TH, Kim MC, Jung GJ, Roh MS et al. (2003). A gene expression in study human gastric adenocarcinoma using a cDNA microarray. Korean J Gastroenterol 42: 484–495.
Lefebvre O, Chenard MP, Masson R, Linares J, Dierich A, LeMeur M et al. (1996). Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 274: 259–262.
Meireles SI, Cristo EB, Carvalho AF, Hirata R, Jr, Pelosof A, Gomes LI et al. (2004). Molecular classifiers for gastric cancer and nonmalignant diseases of the gastric mucosa. Cancer Res 64: 1255–1265.
Moody SE, Perez D, Pan TC, Sarkisian CJ, Portocarrero CP, Sterner CJ et al. (2005). The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8: 197–209.
Mullin JM . (2004). Epithelial barriers, compartmentation, and cancer. Sci STKE 2004: pe2.
Norsett KG, Laegreid A, Midelfart H, Yadetie F, Erlandsen SE, Falkmer S et al. (2004). Gene expression based classification of gastric carcinoma. Cancer Lett 210: 227–237.
Oue N, Hamai Y, Mitani Y, Matsumura S, Oshimo Y, Aung PP et al. (2004). Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res 64: 2397–2405.
Parkin DM . (2004). International variation. Oncogene 23: 6329–6340.
Ramaswamy S, Ross KN, Lander ES, Golub TR . (2003). A molecular signature of metastasis in primary solid tumors. Nat Genet 33: 49–54.
Rugge M, Cassaro M, Di Mario F, Leo G, Leandro G, Russo VM et al. (2003). The long term outcome of gastric non-invasive neoplasia. Gut 52: 1111–1116.
Swisshelm K, Macek R, Kubbies M . (2005). Role of claudins in tumorigenesis. Adv Drug Deliv Rev 57: 919–928.
Tsukuma H, Mishima T, Oshima A . (1983). Prospective study of "early" gastric cancer. Int J Cancer 31: 421–426.
Tsukuma H, Oshima A, Narahara H, Morii T . (2000). Natural history of early gastric cancer: a non-concurrent, long term, follow up study. Gut 47: 618–621.
Van Itallie CM, Anderson JM . (2006). Claudins and Epithelial Paracellular Transport. Annu Rev Physiol 68: 403–429.
Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A et al. (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: research0034.1–research0034.11.
Wang CS, Hsueh S, Chao TC, Jeng LB, Jan YY, Chen SC et al. (1997). Prognostic study of gastric cancer without serosal invasion: reevaluation of the definition of early gastric cancer. J Am Coll Surg 185: 476–480.
Wang TC, Fox JG . (1998). Helicobacter pylori and gastric cancer: Koch's postulates fulfilled? Gastroenterology 115: 780–783.
Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C et al. (2004). Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927–939.
Yu CD, Xu SH, Mou HZ, Jiang ZM, Zhu CH, Liu XL . (2005). Gene expression profile differences in gastric cancer, pericancerous epithelium and normal gastric mucosa by gene chip. World J Gastroenterol 11: 2390–2397.
Acknowledgements
We thank D Nicosia, A Hurtado, G Jodice, the Sequencing and the Affymetrix Services at IFOM for technical assistance. This work was supported by a grant from Cariplo Foundation to GC, and by AIRC (Italian Association for Cancer Research), the European Community (VI Framework), the Italian Ministries of Health, and of Education and University, the Monzino Foundation and the Ferrari Foundation to PPDF.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).
Supplementary information
Rights and permissions
About this article
Cite this article
Vecchi, M., Nuciforo, P., Romagnoli, S. et al. Gene expression analysis of early and advanced gastric cancers. Oncogene 26, 4284–4294 (2007). https://doi.org/10.1038/sj.onc.1210208
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1210208
Keywords
This article is cited by
-
Network and functional analyses of differentially expressed genes in gastric cancer provide new biomarkers associated with disease pathogenesis
Journal of the Egyptian National Cancer Institute (2023)
-
Ventricular Zone Expressed PH Domain Containing 1 (VEPH1): an adaptor protein capable of modulating multiple signaling transduction pathways during normal and pathological development
Cell Communication and Signaling (2019)
-
Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology
Journal of Experimental & Clinical Cancer Research (2019)
-
MicroRNA-335-5p is a potential suppressor of metastasis and invasion in gastric cancer
Clinical Epigenetics (2017)
-
COL11A1/(pro)collagen 11A1 expression is a remarkable biomarker of human invasive carcinoma-associated stromal cells and carcinoma progression
Tumor Biology (2015)